Techne Corp (NASDAQ:TECH)
CAPS Rating:
The Company and its subsidiaries are engaged in the development and manufacture of biotechnology products and hematology calibrators and controls.
Taking it to the street
The Company and its subsidiaries are engaged in the development and manufacture of biotechnology products and hematology calibrators and controls.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
biotech growth for 50 years
This company has had zero EPS growth and zero revenue growth over the last 3 years, why is it worth a P/E of around 25?